Search Results

Curdione 10 mg  | 99.76%

TargetMol

Curdione inhibits CYP3A4 activity and the production of prostaglandin E2. Curdione inhibits proliferation of MCF-7 cells by inducing apoptosis. Curdione may be a candidate for anti-inflammatory and Y chemopreventive agents.

More Information Supplier Page

Trans-ACBD 50 mg  | 99.75%

TargetMol

1-Aminocyclobutane-1, 3-dicarboxylic acid is an effective and specific N-methyl-D-aspartate receptor agonist.

More Information Supplier Page

RO 46-8443 5 mg  | 98.50%

TargetMol

RO 46-8443 is the first non-peptide endothelin ETB receptor selective antagonist. RO 46-8443 displays up to 2000-fold selectivity for ETB receptors both in terms of binding inhibitory potency and functional inhibition.

More Information Supplier Page

RO 46-8443 50 mg  | 98.50%

TargetMol

RO 46-8443 is the first non-peptide endothelin ETB receptor selective antagonist. RO 46-8443 displays up to 2000-fold selectivity for ETB receptors both in terms of binding inhibitory potency and functional inhibition.

More Information Supplier Page

RO 46-8443 2 mg  | 98.50%

TargetMol

RO 46-8443 is the first non-peptide endothelin ETB receptor selective antagonist. RO 46-8443 displays up to 2000-fold selectivity for ETB receptors both in terms of binding inhibitory potency and functional inhibition.

More Information Supplier Page

RO 46-8443 25 mg  | 98.50%

TargetMol

RO 46-8443 is the first non-peptide endothelin ETB receptor selective antagonist. RO 46-8443 displays up to 2000-fold selectivity for ETB receptors both in terms of binding inhibitory potency and functional inhibition.

More Information Supplier Page

RO 46-8443 10 mg  | 98.50%

TargetMol

RO 46-8443 is the first non-peptide endothelin ETB receptor selective antagonist. RO 46-8443 displays up to 2000-fold selectivity for ETB receptors both in terms of binding inhibitory potency and functional inhibition.

More Information Supplier Page

RO 46-8443 100 mg  | 98.50%

TargetMol

RO 46-8443 is the first non-peptide endothelin ETB receptor selective antagonist. RO 46-8443 displays up to 2000-fold selectivity for ETB receptors both in terms of binding inhibitory potency and functional inhibition.

More Information Supplier Page